Hermizi Hapidin

Dr. Hermizi Hapidin

School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2008 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
Hermizi HapidinHermizi Hapidin
Hermizi Hapidin
OFOthman Faizah
Othman Faizah
SISoelaiman Ima-Nirwana
Soelaiman Ima-Nirwana
SNShuid Ahmad Nazrun
Shuid Ahmad Nazrun
MNMohamed Norazlina
Mohamed Norazlina

26 February 2007 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
Hermizi HapidinHermizi Hapidin
Hermizi Hapidin
FOFaizah Othman
Faizah Othman
ISIma-Nirwana Soelaiman
Ima-Nirwana Soelaiman
ASAhmad N. Shuid
Ahmad N. Shuid
DLDouglas A. Luke
Douglas A. Luke
NMNorazlina Mohamed
Norazlina Mohamed

1 January 2013 in Behavioral and Brain Functions
Verified
Journal Article
Open access
PDF file
JKJaya Kumar
Jaya Kumar
Hermizi HapidinHermizi Hapidin
Hermizi Hapidin
YBYvonne-Tee Get Bee
Yvonne-Tee Get Bee
ZIZalina Ismail
Zalina Ismail
Abstinence from chronic ethanol consumption leads to the manifestation of a variety of symptoms attributed to central nervous system hyperexcitability, such as increased irritability, anxiety, and restlessness. Recent studies have demonstrated the importance of metabotropic glutamate receptor 5 (mGluR5) in addictive behaviours. This study investigates the effects of the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) on ethanol withdrawal induced anxiety using two behavioural paradigms. Male Wistar rats were fed a Modified Liquid Diet (MLD) containing low fat cow milk, sucrose, and maltodextrin with a gradual introduction of 2.4%, 4.8% and 7.2% ethanol for 20 days. Six hours into ethanol withdrawal, the rats were intraperitoneally injected with normal saline and MPEP (2.5, 5.0, 10, 20, 30 mg/kg) and were assessed for ethanol withdrawal induced anxiety-like syndrome using an automated elevated plus maze and an open field. MPEP at 10 mg/kg significantly attenuated ethanol withdrawal induced anxiety without any compromising effects on locomotor activities. Despite reversing several indices of ethanol withdrawal induced anxiety in both the elevated plus maze and the open field, low doses of MPEP (2.5, 5 mg/kg) significantly compromised the locomotor activities of ethanol withdrawn rats. High doses of MPEP (20 and 30 mg/kg) significantly attenuated withdrawal anxiety when tested in the elevated plus maze but not in the open field. Administration of MPEP (2.5, 5, 10, 20, 30 mg/kg) has no significant compromising effect on the locomotor activities of ethanol naïve rats. Despite significantly reducing withdrawal anxiety in both behavioural paradigms at 10 mg/kg, the compromising effects of low and high doses of MPEP must be further explored along with the therapeutic efficiency of this drug for relieving withdrawal induced anxiety.

16 October 2010 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
Hermizi HapidinHermizi Hapidin
Hermizi Hapidin
FOFaizah Othman
Faizah Othman
ISIma Nirwana Soelaiman
Ima Nirwana Soelaiman
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
NMNorazlina Mohamed
Norazlina Mohamed

1 February 2016 in Alcohol
Verified
Journal Article
Closed access
JKJaya Kumar
Jaya Kumar
Hermizi HapidinHermizi Hapidin
Hermizi Hapidin
YBYvonne-Tee Get Bee
Yvonne-Tee Get Bee
ZIZalina Ismail
Zalina Ismail

11 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Hermizi HapidinHermizi Hapidin
Hermizi Hapidin
NHNor Munira Hashim
Nor Munira Hashim
MKMohamad Zahid Kasiram
Mohamad Zahid Kasiram
hasmah abdullahhasmah abdullah
hasmah abdullah
Background: This study investigates the effect of tannic acid (TA) combined with pamidronate (PAM) on a human osteoblast cell line. Methods: EC50 for TA, PAM, and different combination ratios of TA and PAM (25:75, 50:50, 75:25) were measured by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The combination index value was utilized to analyze the degree of drug interaction, while trypan blue assay was applied to analyze the cells proliferation effect. The mineralization and detection of bone BSP and Osx genes were determined via histochemical staining and PCR test, respectively. Results: The EC50 of osteoblasts treated with TA and a 75:25 ratio of TA and PAM were more potent with lower EC50 at 0.56 µg/mL and 0.48 µg/mL, respectively. The combination of TA and PAM (75:25) was shown to have synergistic interaction. On Day 7, both TA and PAM groups showed significantly increased proliferation compared with control and combination groups. On Day 7, both the TA and combination-treated groups demonstrated a higher production of calcium deposits than the control and PAM-treated groups. Moreover, on Day 7, the combination-treated group showed a significantly higher expression of BSP and Osx genes than both the TA and PAM groups. Conclusion: Combination treatment of TA and PAM at 75:25 ameliorated the highest enhancement of osteoblast proliferation and mineralization as well as caused a high expression of BSP and Osx genes.